American College of Physicians\and\Infectious Diseases Society of America*.
. Human Immunodeficiency Virus (HIV) Infection. Ann Intern Med. 1994;120:310-319. doi: 10.7326/0003-4819-120-4-199402150-00009
Download citation file:
Published: Ann Intern Med. 1994;120(4):310-319.
Knowledge about the epidemiology, diagnosis, and treatment of human immunodeficiency virus (HIV) infection gained since 1988 has necessitated an update of our previously published policies.Important advances have been made in the treatment of HIV infection and the acquired immunodeficiency syndrome (AIDS), resulting in a prolongation of the symptom-free period. Transmission of HIV infection from a dentist to several of his patients is believed to have occurred. Heterosexual transmission of HIV infection is increasing in importance.
This statement emphasizes the ethical imperative to care for all patients; the need for health care professionals to adhere scrupulously to universal precautions because of the low but definite risk for transmission of HIV in the health care setting; the expanded recommendations for HIV testing to identify infected persons as early as possible; and the need for national leadership in public education, public policy development, and health care funding.
*This position paper was authored by Theodore C. Eickhoff, MD, and was developed for the Infectious Diseases Society of America (IDSA) and the American College of Physicians (ACP) Health and Public Policy Committee by the Clinical Practice Subcommittee: David J. Gullen, MD, Chair; Whitney Addington, MD; Louis M. Aledort, MD; Sandra Adamson Fryhofer, MD; Edgar B. Jackson, Jr., MD; Nicole Lurie, MD; Bruce J. Sams, Jr., MD; John P. Tooker, MD; Constance M. Winslow, MD, MBA. Members of the Health and Public Policy Committee were: Clifton R. Cleaveland, MD, Chair; Cecil O. Samuelson, Jr., MD, Vice-Chair; Robert A. Berenson, MD; Christine K. Cassel, MD; John M. Eisenberg, MD; David J. Gullen, MD; Woodrow A. Myers, Jr., MD; Steven A. Schroeder, MD; Harold C. Sox, Jr., MD; Gerald E. Thomson, MD; Quentin D. Young, MD. Members of the IDSA HIV Committee were: King K. Holmes, MD, PhD, Chair; Donald Armstrong, MD; Donald Burke, MD; Julie Gerberding, MD, MPH; Daniel F. Hoth, MD; Newton E. Hyslop, Jr., MD; Harold W. Jaffe, MD; Henry Masur, MD; John P. Phair, MD; Philip A. Pizzo, MD; Jack S. Remington, MD; Merle A. Sande, MD; Edmund C. Tramont, MD; Catherine M. Wilfert, MD; Constance B. Wofsy, MD. Members of the IDSA Council were: Merle A. Sande, MD, President; Gerald L. Mandell, MD; Vincent T. Andriole, MD; Catherine M. Wilfert, MD; R. Gordon Douglas, MD; Ward E. Bullock, MD; Ellie J. C. Goldstein, MD; Adolf W. Karchmer, MD; Dennis G. Maki, MD; Allan R. Ronald, MD; Walter E. Stamm, MD. The paper was approved by the ACP Board of Regents on 23 March 1992 and by the IDSA Council on 21 March 1993.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Infectious Disease, HIV.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only